Holmium-166 Market Share Driven by Advancements in Liver Tumor Treatments and Radioembolization | Valuates Reports

Holmium-166 Market
The global market for Holmium-166 was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-12K8995/Global_Holmium_166_Market_Research_Report_2022

The Holmium-166 market is experiencing significant growth, primarily fueled by its application in treating liver tumors through selective internal radiation therapy. Holmium-166 microspheres provide precise targeting of tumor tissues while minimizing radiation exposure to surrounding healthy tissues and medical staff. Increasing adoption in clinical settings for hepatocellular carcinoma and other liver malignancies is driving strong demand and shaping overall market trends in the radiopharmaceutical sector.

Among product types, microspheres currently hold the largest market share due to their ability to deliver targeted radiation directly to tumor sites, improving therapeutic outcomes. The "Other" type segment, while smaller, contributes to the diversity of Holmium-166 applications, supporting ongoing research and development efforts that expand the isotope's utility across medical therapies.

In terms of applications, liver tumor treatment represents the dominant segment, underscoring Holmium-166's critical role in oncology. The "Other" applications segment includes emerging uses and experimental therapies, reflecting the market's growth potential as research continues to uncover new medical indications for this radioisotope.

Key players in the Holmium-166 market include Terumo, NRG, and McMaster University. These organizations lead in production, research, and development of Holmium-166 microspheres, implementing strategies that enhance manufacturing efficiency and product availability. Their innovations and collaborations are central to maintaining market leadership and supporting the expansion of Holmium-166 applications worldwide.

Regionally, North America dominates the Holmium-166 market due to advanced healthcare infrastructure and strong investment in medical research. Europe also holds a significant position, with countries such as Germany, France, and the UK driving adoption. The Asia-Pacific region, including China and Japan, is experiencing rapid market growth, propelled by rising healthcare demand and technological advancements. The global market forecast indicates continued expansion, driven by innovation, increased clinical adoption, and evolving regulatory frameworks in oncology therapeutics.

Segment by Type

• Microspheres
• Other

Segment by Application

• Liver Ttumours
• Other

By Company

Terumo, NRG, McMaster University

View full report
https://reports.valuates.com/market-reports/QYRE-Auto-12K8995/global-holmium-166

Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.